Home Cart Sign in  
Chemical Structure| 1835667-63-4 Chemical Structure| 1835667-63-4

Structure of Befotertinib
CAS No.: 1835667-63-4

Chemical Structure| 1835667-63-4

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Befotertinib (D-0316) is a third-generation EGFR tyrosine kinase inhibitor. It is used in research on EGFR T790M-positive non-small cell lung cancer (NSCLC).

Synonyms: D-0316

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Befotertinib

CAS No. :1835667-63-4
Formula : C29H32F3N7O2
M.W : 567.61
SMILES Code : C=CC(NC1=CC(NC2=NC=CC(C3=CN(CC(F)(F)F)C4=C3C=CC=C4)=N2)=C(OC)C=C1N(CCN(C)C)C)=O
Synonyms :
D-0316
MDL No. :MFCD34578252

Safety of Befotertinib

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319
Precautionary Statements:P501-P270-P264-P280-P302+P352-P337+P313-P305+P351+P338-P362+P364-P332+P313-P301+P312+P330

Related Pathways of Befotertinib

RTK
JAK-STAT

Isoform Comparison

Biological Activity

Clinical Trial:

NCT Number Conditions Phases Recruitment Completion Date Locations
NCT03452150 Advanced Non Small Cell Lung C... More >>ancer Less << PHASE1 COMPLETED 2020-12-31 Research Site, Changchun, Jili... More >>n, 130012, China|Research Site, Shanghai, Shanghai, 200030, China|Research Site, Hangzhou, Zhejiang, 310052, China Less <<
NCT03861156 Solid Tumor|NSCLC|EGFR T790M PHASE2 COMPLETED 2023-05-31 Shanghai Chest Hospital, Shang... More >>hai, Shanghai, 200030, China Less <<
NCT06561620 3-year Disease-free Survival PHASE4 RECRUITING 2029-05-01 Fudan University Cancer Center... More >>, Shanghai, Shanghai, 200032, China Less <<

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

1.76mL

0.35mL

0.18mL

8.81mL

1.76mL

0.88mL

17.62mL

3.52mL

1.76mL

Dissolving Methods
Please choose the appropriate dissolution scheme according to your animal administration guide.For the following dissolution schemes, clear stock solution should be prepared according to in vitro experiments, and then cosolvent should be added in turn:

in order to ensure the reliability of the experimental results, the clarified stock solution can be properly preserved according to the storage conditions; The working fluid for in vivo experiment is recommended to be prepared now and used on the same day;

The percentage shown in front of the following solvent refers to the volume ratio of the solvent in the final solution; If precipitation or precipitation occurs in the preparation process, it can be assisted by heating and/or ultrasound.
Protocol 1
Protocol 2
 

Historical Records

Categories